All Type of News
Did the obesity treatment ‘Belviq’ become a blockbuster product in 2 months since its launch?
The Ildong Pharmaceutical’s ambitious work, Belviq, has been unveiled. As a result, the news was that it has recorded KRW 5.3 billion sales in 2 months since its launch. However, it seems to look into a little more ca...
Employees of multinational pharmaceutical companies make KRW 690 million annual sales per an employee in average
Among Korean branches of multinational pharmaceutical companies, the company with the highest sales per an employee was Roche Korea with over KRW 1.2 billion.
The number is KRW 500 million higher than the one of the ...
Hanmi Pharm stating “We would like to coexist and advance with the Korea Pharmaceutical Distribution Association”When it comes to the Korea Pharmaceutical Distribution Association’s (KPDA) protest to oppose to OnlinePharm in front of the headquarters of Hanmi Pharm at 8am today (28th), Han...
|
Domestic pharmaceutical companies arguing “We are highly interested in expansion to the Chinese market, corresponding to the Korea-China FTA”
In order to prepare for the Korea-China FTA overcoming the congested domestic market, domestic pharmaceutical companies have shown interests in expansion to the Chinese pharmaceutical industry.
The Korea Pharmaceutic...
‘Preliminary review for pharmaceutical products only exists in Korea’
‘Korea is the only country to have preliminary reviews for pharmaceutical advertisements.’
Preliminary reviews for pharmaceutical advertisements have caused controversy. As the number of products that has received in...
The Bayer’s labor and management conflict is tentatively settled after the ‘final agreement’ between the company and the union chairperson
Triggered by the labor union chairperson’s self-injury incident, the labor and management conflict of Bayer has been tentatively settled.
According to the industry concerned on the 28th, Gi-hyung Kim, Chairperson of ...
The relation between the Korea Pharmaceutical Distribution Association and Hanmi Pharm has reached its flashpointThe Korea Pharmaceutical Distribution Association (KPDA) and Hanmi Pharm are having a hard time to find a solution point to their conflict over the aggressive promotion of Onlin...
|
“The Asian market is an industrial point,” domestic pharmaceutical companies paying attention in the reverse innovation
In order to target the Asian market, domestic pharmaceutical companies have accelerated their localization planning. The industry pays attention on the active localizing strategies, such as taking over foreign pharmac...
The KRW 600 billion antithrombotic industry is showing high interests in rapid growth of new products
Antithrombotic products, which have been 3 years since their launch, are energizing its depressed market through their rapid growth.
Particularly, Cilostan (Korea United Pharm) and Brilinta (AstraZeneca) have become ...
Will Hanmi Pharm monopolize the antismoking cessation market after winning the patent trial against ‘Champix’?The government has promoted antismoking by providing antismoking wishers financial supports on maximum 6 sessions of smoking cessation counseling within 12 weeks and antismoking...
|
